Pulmonary/Respiratory Medicine CME

Credits: 0.50 CME
Medical Learning Institute, Inc.
Making the Case for Treating Iron Deficiency in Patients With Heart Failure
Javed Butler, MD, MPH, MBA
December 9, 2020
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Personalizing and Prolonging Care in GIST: Expert Guidance on Integrating New TKI Strategies
Margaret von Mehren, MD
December 8, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
The Case for Challenging Conventional Care in Tenosynovial Giant Cell Tumor: Insights on Integrating Targeted Therapy Into Multimodal Management
William D. Tap, MD
December 7, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Navigating the Relationship Between Type 2 Inflammation and Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy
Professor Ian M. Adcock, PhD, FRSB, FBPhS, FERS
December 7, 2020
Credits: 0.50 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Understanding the Relationship Between Type 2 Inflammation, Atopic Diseases, and Treatment Selection: Practical Strategies for the Healthcare Team to Improve Patient Care
Jonathan A. Bernstein, MD
December 4, 2020
Credits: 0.50 CME / NCPD / CPE
Penn State College of Medicine / Medical Learning Institute, Inc.
Management of Hyperkalemia in Patients With Hemodialysis-Dependent Chronic Kidney Disease: Applying New Evidence and Best Practices for Improved Patient Outcomes
Steven Fishbane, MD
December 3, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Unraveling the Intricacies of HCC Management With Your Multidisciplinary Team: A Closer Look at Effective Selection and Sequencing Strategies in an Expanding Treatment Landscape
Amit Singal, MD, MS
December 1, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Molecular Testing and Targeted Therapies in NSCLC: Essential Guidance for Modern Patient-Centered Precision Lung Cancer Care
Suresh S. Ramalingam, MD, FACP, FASCO
November 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment
Eric Gapud, MD, PhD
November 30, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Evolving Treatment Landscape of SSc-ILD: Strategies to Improve Recognition and Management
Flavia Castelino, MD
November 25, 2020
Credits: 1.50
PeerView Institute
Emergency Department on Alert: Solving Oncologic Emergency Quandaries During the Immuno-Oncology Era and COVID-19 Pandemic
Jarushka Naidoo, MB, BCH, MHS
November 20, 2020
Credits: 1.00
PeerView Institute
Solutions for Tenosynovial Giant Cell Tumors: Employing Effective Multimodal and Multidisciplinary Approaches to Patient Care
Kristen Ganjoo, MD
November 19, 2020
Credits: 1.00 CME
PeerView Institute
Modernizing Your Radiation Oncology Practice With Tumor Treating Fields and Other Novel Multimodal Strategies: Understanding the Science, Evidence, and Practical Aspects Across a Range of Solid Tumors
Hani M. Babiker, MD
November 12, 2020
Credits: 1.50 CME / MOC / CNE / CPE
PeerView Institute
Immunotherapy in the Treatment Arsenal for Small Cell Lung Cancer, and Managed Care Implications for the Four Ps: Patient, Provider, Pharmacy, and Plan
Stephen V. Liu, MD
Bhavesh Shah, RPh, BCOP
November 12, 2020
Credits: 1.00 CME
PeerView Institute
Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest Data and Practical Guidance for Thoracic Surgeons and the Multidisciplinary Team on the Emerging Role of EGFR-Targeted Therapy in Resectable Lung Cancer
David R. Jones, MD
November 11, 2020
Credits: 1.50
PeerView Institute
Managed Care Implications of the Expanding Role of PARP Inhibitors in Oncology: Evolving Evidence Base, Current Value Assessment Frameworks, and Considerations for Decision-Making in Managed Care Settings
Kathleen N. Moore, MD, MS / Kristi Jhangiani, PharmD, BCPS
November 6, 2020
Credits: 1.00 CME
PeerView Institute
Progressive Pathways: Recent Recommendations and Emerging Therapies for Treating NF1-Associated Tumors
Roger J. Packer, MD
November 5, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Reducing the Burden of Influenza on Children: An Exploration of Novel and Emerging Antiviral Therapy
Jesse Papenburg, MD, MSc, FRCPC
October 8, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Differential Diagnosis of Interstitial Lung Diseases: Interpreting HRCT Accurately and Working With a Multidisciplinary Approach
August 21, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
How I Think, How I Treat – Contemporary Insights on Diagnosing and Managing SSc-ILD in an Evolving Treatment Landscape
Lisa H. Lancaster, MD
August 19, 2020
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Building on Progress to Further Advance Care for Patients With EGFR Mutation–Positive NSCLC: A Look at Emerging Precision Medicine Strategies Encompassing Acquired Resistance, Treatment Sequencing, and Patient Considerations
Edward Garon, MD, MS
August 10, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Toward Expanded Precision Treatment of HER2- or HER3-Driven Breast, Gastrointestinal, Lung, and Other Cancers: Current Challenges, Opportunities for Improvement, and Practical Considerations
Erika Hamilton, MD
August 6, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Finding the Path to Improved Outcomes in Uncontrolled Persistent Asthma: Applying the Latest Clinical Evidence for Treatment Success
Cedric "Jamie" Rutland, MD
July 28, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Coronavirus Disease 2019 (COVID-19): Need-to-Know Information and Practical Guidance for Healthcare Professionals on the Front Lines of Patient Care
Paul E. Sax, MD
July 24, 2020
Credits: 1.00 CME / MOC / CC / CNE / CPE
Medical Learning Institute, Inc.
It's Precisely the Time for More Precision in Genomic Testing and Targeted Treatment of NSCLC
Rebecca S. Heist, MD, MPH
July 23, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 25, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes for Patients With Nontuberculous Mycobacterial Lung Disease: Navigating the Complexities of Diagnosis and Management
Kevin Winthrop, MD, MPH
June 23, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
June 15, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take on Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 10, 2020

Pages